AARTI PHARMALABS
|
AARTI PHARMALABS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|
Profit Before Tax | ₹261 Cr | ₹155 Cr | ₹0.00 Cr |
Adjustment | ₹82 Cr | ₹52 Cr | - |
Changes In working Capital | ₹-17 Cr | ₹-230 Cr | ₹0.00 Cr |
Cash Flow after changes in Working Capital | ₹325 Cr | ₹-23 Cr | - |
Cash Flow from Operating Activities | ₹263 Cr | ₹-44 Cr | - |
Cash Flow from Investing Activities | ₹-158 Cr | ₹-139 Cr | - |
Cash Flow from Financing Activities | ₹-163 Cr | ₹260 Cr | - |
Net Cash Inflow / Outflow | ₹-58 Cr | ₹78 Cr | - |
Opening Cash & Cash Equivalents | ₹83 Cr | ₹5.33 Cr | ₹0.25 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - |
Closing Cash & Cash Equivalent | ₹25 Cr | ₹83 Cr | ₹0.25 Cr |
Compare Cashflow Statement of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹5,315.5 Cr | 18.5% | 30.6% | 63% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹366,354.0 Cr | 2.3% | -0.8% | 60.8% | Stock Analytics | |
CIPLA | ₹113,516.0 Cr | 3.5% | 0.7% | 43.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,352.0 Cr | 2.7% | 3% | 17.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,367.0 Cr | 3.1% | 3.8% | 91.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,961.5 Cr | -0.1% | -3.5% | 29.5% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | 18.5% |
30.6% |
63% |
SENSEX | -0.7% |
-2.7% |
17.8% |
You may also like the below Video Courses